Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,335 recruiting studies in this area right now.
By phase
- Not applicable4,398
- Phase 2610
- Phase 1411
- Phase 3321
- Phase 4271
- Phase 1/Phase 2254
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer338
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer190
- Acute Kidney Injury137
- Endometriosis135
- Pregnancy132
- Chronic Kidney Diseases131
- Breast Cancer107
- Chronic Kidney Disease105
- Infertility94
- Renal Cell Carcinoma81
- Colorectal Cancer74
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Pregnancy Complications63
- Urinary Incontinence63
Leading sponsors
- Mayo Clinic58
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS48
- Assistance Publique - Hôpitaux de Paris47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)41
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca35
Where studies are running
- California345
- Alabama155
- Texas121
- Massachusetts119
- New York118
- Florida103
- Arizona100
- Colorado90
- Maryland89
- Illinois78
Recruiting studies6,335 total
- NCT05656261Recruiting
Genetic testing study for African Americans
This study looks at genetic markers (genes) related to kidney risk in Black/African American adults. It may help researchers better understand who is at higher risk and how genetics could guide future care.
St Louis, MissouriAges 18–90 - NCT05656235RecruitingPhase 2
Study of keeping kidneys longer in upper tract bladder cancer
This Phase 2 trial studies whether a combination treatment can control high-grade upper tract urothelial cancer without removing the kidney and ureter (radical nephroureterectomy). It may help people who must avoid surgery or choose not to have it because of medical risk.
Washington D.C., District of ColumbiaAges 18 years+ - NCT05657990RecruitingEarly Phase 1
Preventing trouble peeing after chest cancer surgery
This early-phase trial tests whether taking tamsulosin-like treatment around the time of chest cancer surgery can prevent urinary retention, when people cannot pee after surgery. It may help lower the chance of needing extra catheter care after the operation.
Brick, New JerseyAges 55 years+ - NCT05659381RecruitingPhase 3
Heated belly chemo plus niraparib after interval surgery for ovarian cancer
This Phase 3 study tests whether heated chemotherapy placed inside the belly, followed by interval surgery and the maintenance medicine niraparib, can improve outcomes for certain advanced ovarian, fallopian tube, or primary peritoneal cancers. It focuses on people whose tumors are HRD/LOH positive and who can have all visible disease removed.
Duarte, CaliforniaAges 18 years+ - NCT05659589Recruiting
Using a kidney toxin level to predict heart effects in AKI
This study looks at whether measuring indoxyl sulfate, a substance that can build up when kidneys are injured, can help predict how blood vessels and the heart are affected during acute kidney injury (AKI). It may help doctors understand who is at higher risk of heart-related problems while AKI is happening.
AmiensAges 18 years+ - NCT05662462Recruiting
Phone coaching to keep blood sugar in range during pregnancy
This study tests whether technology plus coaching can help pregnant people with type 2 diabetes keep their blood sugar in a healthy target range. You may use a smartphone app and, if assigned to that group, a device that tracks glucose continuously.
Columbus, OhioAges 18 years+ - NCT05662696Recruiting
Telemonitoring for pregnant people at high risk of preeclampsia
This study tests whether a home telemonitoring program (sending health readings from home) is practical and helpful for people at high risk for preeclampsia. It may help catch warning signs earlier and support safer care during the first half of pregnancy.
Karachi, SindhAges 18 years+ - NCT05663710RecruitingPhase 1/Phase 2
Study of 177Lu antibody and medicines for first advanced kidney cancer
This trial tests a new combination of targeted medicines (including 177Lu girentuximab) plus immunotherapy to treat people with advanced clear cell kidney cancer who have not had prior systemic (whole-body) treatment. It aims to shrink tumors and control disease by attacking cancer in multiple ways.
Houston, TexasAges 18 years+ - NCT05665361RecruitingPhase 1/Phase 2
Testing palbociclib plus sasanlimab for advanced kidney cancers
This study tests a combination of two medicines—palbociclib and sasanlimab—in people with advanced clear cell or papillary kidney cancer. It’s mainly designed to check safety (and early signs of how well the treatment may work) in these cancer types.
Bethesda, MarylandAges 18–100 - NCT05669430RecruitingPhase 1/Phase 2
Testing an anti-cancer drug alone and with pembrolizumab
This early-phase study tests GV20-0251 (an anti-cancer treatment) by itself and combined with pembrolizumab, to see how well it works and how safe it is. It is for adults with advanced solid tumors that have grown despite standard treatments, or where standard treatments aren’t an option.
Los Angeles, CaliforniaAges 18 years+ - NCT05669950RecruitingPhase 1/Phase 2
Study drug Lu AG13909 for congenital adrenal hyperplasia
This early study tests Lu AG13909 in people with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. It aims to see how the drug affects hormone levels and whether it is safe for different CAH hormone patterns.
Ann Arbor, MichiganAges 18–70 - NCT05672615Recruiting
Mood changes during bladder cancer treatment with BCG
This study looks at how bladder cancer treatment with BCG may affect mood and emotional well-being. It may help doctors understand which patients experience mood changes during care.
Washington D.C., District of ColumbiaAges 18 years+ - NCT05674487Recruiting
Balloon vs prostaglandin medicine to start labor in small babies
This trial compares two ways to help start labor by the vagina in pregnancies where the baby is measuring small. It aims to see which method works better and is safer for getting birth when needed.
BordeauxAges 18 years+ - NCT05674799Recruiting
Program to lower future obesity and diabetes risks
This trial tests a lifestyle and coaching program (NDPP-NextGen) to help reduce the chances of obesity and diabetes risk passing to the next generation. It’s for people planning a pregnancy soon and who may be at higher risk due to body weight.
Winston-Salem, North CarolinaAges 18–39 - NCT05675787RecruitingPhase 2
Hormone and cholesterol medicines for early womb lining cancer or precancer
This trial tests whether medroxyprogesterone acetate (a progesterone hormone) plus atorvastatin (a cholesterol medicine) can treat early, limited problems in the womb lining—either atypical hyperplasia or early cancer (Grade 1) that has not spread into the muscle wall. It may help shrink or clear the abnormal tissue while supporting keeping fertility and the uterus.
Beijing, Beijing MunicipalityAges 17–45 - NCT05675397Recruiting
Donor milk supplement for very small preterm babies
This study looks at giving donor human milk to very low-birth-weight preterm babies when a mother’s own milk is not enough during the first three weeks. It may help babies get human milk instead of formula during that early period.
AthensAges 1 day–3 weeks - NCT05675969Recruiting
Testing tiny blood particles in at-risk early delivery
This pilot study looks at tiny particles in blood (microvesicles) to learn how they differ in women with threatened preterm delivery, with or without pre-eclampsia. Results may help doctors better identify risk and improve care for early delivery.
BordeauxAges 18 years+ - NCT05676476Recruiting
Tested extra blood-pressure control to extend pregnancy in preeclampsia
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
Birmingham, AlabamaAges 14–49 - NCT05676918Recruiting
Postpartum well-being study for mothers in the past year
This study looks at mothers’ well-being after having a baby, to understand what affects mental and emotional health after childbirth. It may help improve support for mothers during the postnatal period.
Madrid, Pozuelo de AlarcónAges 18 years+ - NCT05677269Recruiting
Compare surgery for bowel endometriosis versus IVF pathway
This trial studies whether surgically removing colorectal (bowel) endometriosis works better and is more cost-effective than choosing an IVF/ICSI treatment plan. It’s for people who want to get pregnant and are deciding between surgery and fertility treatments.
EindhovenAges 21–40 - NCT05678413Recruiting
Paclitaxel study for short anterior urethral narrowing
This study looks at whether paclitaxel can help treat a short narrowing (stricture) in the front part of the urethra. You might be considered if your symptoms and urine flow match specific cutoffs and if you have not had prior treatment for this problem.
CairoAges 18 years+ - NCT05678062Recruiting
Ultrasound checks for seizures in preeclampsia
This study looks at using a quick ultrasound at the bedside to find possible causes or warning signs in people with preeclampsia who develop new seizures. It may help clinicians recognize problems sooner and guide safer treatment.
Cape Town, Western CapeAges 18 years+ - NCT05679024RecruitingPhase 3
Apixaban to prevent stroke in atrial fibrillation and kidney failure
This trial tests apixaban (a blood thinner) to prevent stroke in people with atrial fibrillation or atrial flutter who have very poor kidney function or are on dialysis. If you qualify, you may help researchers find a safer way to lower stroke risk for this higher-risk group.
HelsinkiAges 18 years+ - NCT05678543Recruiting
Diabetes family registry for mothers, partners, and children
This study builds a registry to learn about diabetes in families over time. It includes mothers with diabetes, their partners, and their children, to help researchers understand how diabetes affects families.
AalborgAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,335 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,288 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.